The Latest Breaking News on Pharma

China’s National Health Commission is scaling down its daily COVID-19 report in response to a sharp decline in PCR testing since the government eased anti-virus measures after daily cases hit record highs

The Department of Industrial Works (DIW) has told at least 141 companies to register their stock of poisonous sodium cyanide, widely used in mining and as a pesticide, by Thursday.

The pharmaceutical industry is well-positioned to witness substantial growth, driven by the prevalence of chronic diseases, the aging population, and increased healthcare spending. Given the industry’s promising growth prospects, we think it could be wise to invest in fundamentally sound pharmaceutical stocks Johnson & Johnson (JNJ), Merck & Co (MRK),…

Biotech industry played a vital role amid the pandemic and continues to witness solid demand amid rising medical needs and chronic diseases. Investor sentiment toward biotech stocks is robust. As biotech is considered a defensive sector against market downturns, investors might buy quality biotech stocks Gilead Sciences (GILD), Biogen (BIIB),…

Florida Gov. Ron DeSantis is asking the state’s Supreme Court to convene a grand jury to investigate “any and all wrongdoing” with respect to the COVID-19 vaccines

(This Dec.13 story has been corrected to remove reference to Sanofi in the fifth paragraph)

Concerns raised over pharmacists’ losses as market prices outpace NHS reimbursement tariffs

Department says "system has been working hard to replenish stocks as quickly as possible"

Thank you, science.